FDA.reportPublic FDA data

Threda 17.5 MG/ML Oral Suspension

RxCUI
1437923
RxNorm name
Threda 17.5 MG/ML Oral Suspension
Display name
Threda 17.5 MG/ML Oral Suspension
Full name
Threda 17.5 MG/ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5d997ba1-1139-4f94-99b2-1cca065ce27cTHREDA 262 MG in 15 mL Oral Suspension [PSN] · bismuth subsalicylate 17.5 MG/ML Oral Suspension [Threda] [SBD] · Threda 17.5 MG/ML Oral Suspension [SY] · Threda 262 MG per 15 ML Oral Suspension [SY]4120130919